HER2 MUTANT NON-SMALL CELL LUNG CANCER

HER2 MUTANT NON-SMALL CELL LUNG CANCER was reported 11 times

HER2 MUTANT NON-SMALL CELL LUNG CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ZONGERTINIB 2 0.0120
1 AFATINIB 3 0.0005
2 NERATINIB 1 0.0004
3 RAMUCIRUMAB 1 0.0002
4 PEMETREXED DISODIUM 6 0.0002
5 TRASTUZUMAB 4 0.0001
6 BEVACIZUMAB 6 0.0000
7 CARBOPLATIN 5 0.0000
8 DOCETAXEL 2 0.0000
9 DOCETAXEL ANHYDROUS 2 0.0000
10 ETOPOSIDE 1 0.0000
11 CISPLATIN 1 0.0000
12 NIVOLUMAB 1 0.0000